{"id":4301,"date":"2023-03-08T09:17:00","date_gmt":"2023-03-08T08:17:00","guid":{"rendered":"https:\/\/www.amyloidosisalliance.org\/un-programa-de-television-sueco-sobre-crispr-cas9\/"},"modified":"2026-11-03T10:23:35","modified_gmt":"2026-11-03T09:23:35","slug":"un-programa-de-television-sueco-sobre-crispr-cas9","status":"publish","type":"post","link":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/","title":{"rendered":"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Este programa se llama \u00abFr\u00e5ga Doktorn\u00bb (Pregunte al doctor) y se emite en Suecia. Cada semana trata un tema especial y esta vez estuvo dedicado a CRISPR-Cas9 y a la amiloidosis por transtiretina.<br\/>Los espectadores tambi\u00e9n pueden enviar sus preguntas durante el programa. La presentadora (con camisa rosa) y la m\u00e9dica (con blusa de flores) reciben en este programa a Mats Br\u00e4nnstr\u00f6m (tambi\u00e9n m\u00e9dico), uno de los primeros en recibir un tratamiento con CRISPR-Cas9, y al cardi\u00f3logo Bj\u00f6rn Pilebro, m\u00e9dico adjunto s\u00e9nior (responsable del estudio en el Hospital Universitario de Ume\u00e5).<br\/><img loading=\"lazy\" decoding=\"async\" style=\"border-width: 0px;\" src=\"https:\/\/static.xx.fbcdn.net\/images\/emoji.php\/v9\/t1f\/2\/16\/27a1.png\" alt=\"&#x27A1;&#xFE0F;\" width=\"16\" height=\"16\"\/> <a href=\"https:\/\/www.svtplay.se\/video\/e4okoWb\/fraga-doktorn\/sa-kan-gensaxen-bota-sjukdomar?position=764&amp;id=e4okoWb\">Haga clic aqu\u00ed para verlo<\/a><br\/>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un programa de televisi\u00f3n sueco dedicado a la edici\u00f3n gen\u00e9tica en la amiloidosis por transtiretina, con un paciente tratado en un estudio y el cardi\u00f3logo que lo dirige en Ume\u00e5.<\/p>\n","protected":false},"author":1,"featured_media":4302,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[52],"tags":[],"class_list":["post-4301","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-es"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9<\/title>\n<meta name=\"description\" content=\"Un programa de televisi\u00f3n sueco dedicado a la edici\u00f3n gen\u00e9tica en la amiloidosis por transtiretina, con un paciente tratado en un estudio y el cardi\u00f3logo que lo dirige en Ume\u00e5.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9\" \/>\n<meta property=\"og:description\" content=\"Un programa de televisi\u00f3n sueco dedicado a la edici\u00f3n gen\u00e9tica en la amiloidosis por transtiretina, con un paciente tratado en un estudio y el cardi\u00f3logo que lo dirige en Ume\u00e5.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/\" \/>\n<meta property=\"og:site_name\" content=\"Amyloidosis Alliance\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmyloidosisAlliance\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-08T08:17:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-03T09:23:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/08\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"880\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:site\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/\"},\"author\":{\"name\":\"Amyloidosis Alliance\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#organization\"},\"headline\":\"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9\",\"datePublished\":\"2023-03-08T08:17:00+00:00\",\"dateModified\":\"2026-11-03T09:23:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/\"},\"wordCount\":115,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg\",\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/\",\"name\":\"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg\",\"datePublished\":\"2023-03-08T08:17:00+00:00\",\"dateModified\":\"2026-11-03T09:23:35+00:00\",\"description\":\"Un programa de televisi\u00f3n sueco dedicado a la edici\u00f3n gen\u00e9tica en la amiloidosis por transtiretina, con un paciente tratado en un estudio y el cardi\u00f3logo que lo dirige en Ume\u00e5.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg\",\"width\":880,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/un-programa-de-television-sueco-sobre-crispr-cas9\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/inicio\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/\",\"name\":\"Amyloidosis Alliance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#organization\",\"name\":\"Amyloidosis Alliance\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"width\":252,\"height\":252,\"caption\":\"Amyloidosis Alliance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmyloidosisAlliance\\\/\",\"https:\\\/\\\/x.com\\\/amyloidosisa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9","description":"Un programa de televisi\u00f3n sueco dedicado a la edici\u00f3n gen\u00e9tica en la amiloidosis por transtiretina, con un paciente tratado en un estudio y el cardi\u00f3logo que lo dirige en Ume\u00e5.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/","og_locale":"es_ES","og_type":"article","og_title":"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9","og_description":"Un programa de televisi\u00f3n sueco dedicado a la edici\u00f3n gen\u00e9tica en la amiloidosis por transtiretina, con un paciente tratado en un estudio y el cardi\u00f3logo que lo dirige en Ume\u00e5.","og_url":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/","og_site_name":"Amyloidosis Alliance","article_publisher":"https:\/\/www.facebook.com\/AmyloidosisAlliance\/","article_published_time":"2023-03-08T08:17:00+00:00","article_modified_time":"2026-11-03T09:23:35+00:00","og_image":[{"width":880,"height":500,"url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/08\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_creator":"@amyloidosisa","twitter_site":"@amyloidosisa","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/#article","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/"},"author":{"name":"Amyloidosis Alliance","@id":"https:\/\/www.amyloidosisalliance.org\/es\/#organization"},"headline":"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9","datePublished":"2023-03-08T08:17:00+00:00","dateModified":"2026-11-03T09:23:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/"},"wordCount":115,"commentCount":0,"publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/#organization"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/#primaryimage"},"thumbnailUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/08\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg","inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/","url":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/","name":"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/#primaryimage"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/#primaryimage"},"thumbnailUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/08\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg","datePublished":"2023-03-08T08:17:00+00:00","dateModified":"2026-11-03T09:23:35+00:00","description":"Un programa de televisi\u00f3n sueco dedicado a la edici\u00f3n gen\u00e9tica en la amiloidosis por transtiretina, con un paciente tratado en un estudio y el cardi\u00f3logo que lo dirige en Ume\u00e5.","breadcrumb":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/#primaryimage","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/08\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/08\/INSTA-ALLIANCE-880-\u00d7-500-px.jpg","width":880,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.amyloidosisalliance.org\/es\/un-programa-de-television-sueco-sobre-crispr-cas9\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.amyloidosisalliance.org\/es\/inicio\/"},{"@type":"ListItem","position":2,"name":"Un programa de televisi\u00f3n sueco sobre CRISPR-Cas9"}]},{"@type":"WebSite","@id":"https:\/\/www.amyloidosisalliance.org\/es\/#website","url":"https:\/\/www.amyloidosisalliance.org\/es\/","name":"Amyloidosis Alliance","description":"","publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.amyloidosisalliance.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.amyloidosisalliance.org\/es\/#organization","name":"Amyloidosis Alliance","url":"https:\/\/www.amyloidosisalliance.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.amyloidosisalliance.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","width":252,"height":252,"caption":"Amyloidosis Alliance"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmyloidosisAlliance\/","https:\/\/x.com\/amyloidosisa"]}]}},"_links":{"self":[{"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/posts\/4301","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/comments?post=4301"}],"version-history":[{"count":1,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/posts\/4301\/revisions"}],"predecessor-version":[{"id":4303,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/posts\/4301\/revisions\/4303"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/media\/4302"}],"wp:attachment":[{"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/media?parent=4301"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/categories?post=4301"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/tags?post=4301"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}